This systematic review and network meta-analysis found that spinal cord stimulation therapies for treatment of chronic pain in back and/or lower extremities were associated with greater improvements ...

This systematic review and network meta-analysis found that spinal cord stimulation therapies for treatment of chronic pain ...

Muscle stimulators are an effective drug-free pain relief device that can also be used for back pain. They are tested for safety and ability to block the pain signal to your brain while increasing ...

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...

A key highlight of the quarter came right at the end when Nevro won FDA approval for HFX AdaptiveAI, an AI-powered, ...

US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...

In this review, we'll cover all you need to know about the TheraFoot Pro foot massager, including how it treats foot pain and ...

Nov. 12, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, ...

Chris Patterson retired before Christmas 2022, after falling and breaking his back. He has faced several issues trying to get ...

The global spinal cord stimulators market is on a robust growth trajectory, poised to reach an impressive valuation of USD 5,441.4 million by 2033. Currently valued at USD 2,702.7 million in 2023, the ...

Nevro's HFX iQ spinal cord stimulator earned the European Union's CE mark, the company said Nov. 12.